The objectives of this research are (1) to test the hypothesis that human cells treated in long-term, low-dose assays with complex mixtures of chemicals associated with respirable particles from urban air and combustion sources will achieve a constant low rate of mutation as has been observed in experiments with individual mutagenic compounds, (2) to quantify known human cell mutagens in these samples to better understand the relationship between sample composition and mutation rate, (3) to determine the sources and geographic distribution of human cell mutagens in respirable particle samples collected at five sites at the northeast United States, and (4) to determine the key reaction mechanisms by which mutagens are formed in combustion so as to reduce or avoid their formation. Large-quantity samples (in excess of 20 g) of respirable particles (i.e., those particles < approximately 2-3 microns in diameter) will be collected from urban air and from combustion sources known to contribute to the atmospheric load of human cell mutagens (i.e., wood and cigarette smoke, diesel and gasoline engine exhaust, and natural gas burner exhaust). Whole extracts of these samples, extract fractions enriched in PAH and oxy-PAH, and intact particles will be tested in human cells using the long-term (i.e.,>10 days), low-dose assay protocol. GC-MS analysis will be used to determine the composition of human cell mutagens in these samples. In addition, an ongoing analysis of a set of year-long respirable particle samples collected at five sites in the northeastern US-three sites in Massachusetts and two in western New York-will be completed using bioassay-directed chemical analysis to identify human mutagens that contribute significantly to the total mutagenicity of the samples. The results from the northeastern samples will be compared with those obtained from a similar set of respirable particle samples collected in the Los Angeles basin to determine whether there are significant regional differences in human cell mutagenicity and chemical composition. The contribution of various emission sources to the atmospheric samples will be determined via source/receptor modeling techniques to provide insight as to how the emissions from air pollution led to the observed human cell mutagenicity. Finally, the key intermediates, reaction mechanisms and rates of formation of combustion-generated human mutagens, particularly PAH and oxy-PAH, will be studied in laboratory combustors with the goal of understanding how to reduce or avoid the formation of human mutagens in practical combustors. We have learned as part of this research that emission from natural gas burners account for nearly 50% of the total mutagenicity in atmospheric respirable particles; therefore, particular emphasis will be given to the study of mutagen formation in natural gas combustion reactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
5P01ES007168-05
Application #
6106412
Study Section
Project Start
1999-08-01
Project End
2000-07-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Zheng, Weiming; Khrapko, Konstantin; Coller, Hilary A et al. (2006) Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat Res 599:11-20
Coller, Hilary A; Khrapko, Konstantin; Herrero-Jimenez, Pablo et al. (2005) Clustering of mutant mitochondrial DNA copies suggests stem cells are common in human bronchial epithelium. Mutat Res 578:256-71
Pedersen, Daniel U; Durant, John L; Taghizadeh, Koli et al. (2005) Human cell mutagens in respirable airborne particles from the northeastern United States. 2. Quantification of mutagens and other organic compounds. Environ Sci Technol 39:9547-60
Pedersen, Daniel U; Durant, John L; Penman, Bruce W et al. (2004) Human-cell mutagens in respirable airborne particles in the northeastern United States. 1. Mutagenicity of fractionated samples. Environ Sci Technol 38:682-9
Tomita-Mitchell, Aoy; Ling, Losee Lucy; Glover, Curtis L et al. (2003) The mutational spectrum of the HPRT gene from human T cells in vivo shares a significant concordant set of hot spots with MNNG-treated human cells. Cancer Res 63:5793-8
Luo, Wen; Gurjuar, Rajan; Ozbal, Can et al. (2003) Quantitative detection of benzo[alpha]pyrene diolepoxide-DNA adducts by cryogenic laser induced fluorescence. Chem Res Toxicol 16:74-80
Kim, Andrea S; Thilly, William G (2003) Ligation of high-melting-temperature 'clamp' sequence extends the scanning range of rare point-mutational analysis by constant denaturant capillary electrophoresis (CDCE) to most of the human genome. Nucleic Acids Res 31:e97
Muniappan, Brindha P; Thilly, William G (2002) The DNA polymerase beta replication error spectrum in the adenomatous polyposis coli gene contains human colon tumor mutational hotspots. Cancer Res 62:3271-5
Kim, Andrea S; Holmquist, Gerald P; Thilly, William G (2002) High-efficiency DNA ligation for clamp attachment without polymerase chain reaction. Anal Biochem 310:179-85
Zheng, Weiming; Marcelino, Luisa A; Thilly, William G (2002) Scanning low-frequency point mutants in the mitochondrial genome using constant denaturant capillary electrophoresis. Methods Mol Biol 197:93-106

Showing the most recent 10 out of 36 publications